Roche News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

03.04.24	Genprex Expands Trial Sites For Reqorsa Therapy-Tecentriq Trial In Small Cell Lung Cancer; Stock Up (RTTNews)
26.03.24	Roche receives FDA approval for the first molecular test to screen for malaria in blood donors (Roche Holding AG)
20.03.24	Lonza To Acquire U.S. Biologics Site From Roche For $1.2 Bln (RTTNews)
12.03.24	Roche Annual General Meeting 2024 (Roche Holding AG)
25.02.24	New England Journal of Medicine publishes Phase III data showing Xolair significantly reduced allergic reactions across multiple foods in people with food allergies (Roche Holding AG)
20.02.24	It's A First; Cellular Therapy For Melanoma And Drug To Reduce Food Allergic Reactions Get FDA Nod (RTTNews)
16.02.24	FDA approves Xolair as first and only medicine for children and adults with one or more food allergies (Roche Holding AG)
13.02.24	Roche, PathAI Collaborate To Expand Digital Pathology Capabilities For Companion Diagnostics (RTTNews)
01.02.24	Genentech Reports 72-week Data From Global Phase 3 Studies, BALATON And COMINO (RTTNews)
01.02.24	New long-term data for Roche’s Vabysmo show sustained retinal drying and vision improvements in retinal vein occlusion (RVO) (Roche Holding AG)
01.02.24	[Ad hoc announcement pursuant to Art. 53 LR] Roche exceeds guidance and achieves sales growth of 1% (CER) for 2023 despite sharp COVID-19 sales decline (Roche Holding AG)
26.01.24	Genentech's Vabysmo Shows Sustained Benefits In Long-Term Studies For Retinal Vein Occlusion (RTTNews)
22.01.24	AC Immune To Regain Global Rights To Crenezumab And Semorinemab As Deal With Roche Ends (RTTNews)
16.01.24	Roche: European Commission Grants Marketing Authorisation For Tecentriq SC (RTTNews)
16.01.24	European Commission approves Roche’s Tecentriq SC, the EU's first PD-(L)1 cancer immunotherapy subcutaneous injection for multiple cancer types (Roche Holding AG)
03.01.24	Roche Collaborates With Remix Therapeutics To Leverage REMaster Drug Discovery Platform (RTTNews)
29.12.23	Roche enters into a definitive agreement to acquire LumiraDx's Point of Care technology combining multiple diagnostic modalities on a single platform (Roche Holding AG)
19.12.23	Roche Holding's SBLA For Xolair Granted Priority Review By FDA (RTTNews)
19.12.23	FDA grants priority review to Xolair (omalizumab) for children and adults with food allergies based on positive National Institutes of Health phase III study results (Roche Holding AG)
19.12.23	Roche navify digital solutions get excellent ratings from healthcare professionals in KLAS Research reports (PR Newswire)
15.12.23	Roche named among top three most sustainable healthcare companies in the Dow Jones Sustainability Indices (Roche Holding AG)
11.12.23	New data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphoma (Roche Holding AG)
11.12.23	Genentech : Longer-term Data From Studies Of Columvi & Lunsumio Show Durable Responses In Lymphomas (RTTNews)
09.12.23	New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A (Roche Holding AG)
08.12.23	Roche’s inavolisib combination reduces the risk of disease progression by 57% in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation (Roche Holding AG)
05.12.23	Roche announces positive Phase III results for inavolisib combination in people with advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation (Roche Holding AG)
04.12.23	Roche To Acquire Carmot Therapeutics For $2.7 Bln Cash Plus Milestone Payments (RTTNews)
04.12.23	Roche enters into a definitive merger agreement to acquire Carmot Therapeutics, including three clinical stage assets with best-in-class potential in obesity and diabetes (Roche Holding AG)
30.11.23	ShapeTX Expands Ongoing Collaboration With Roche (RTTNews)
27.11.23	Roche expands hepatitis diagnostics portfolio to help clinicians diagnose and monitor patients with acute or chronic hepatitis B infection (Roche Holding AG)
21.11.23	Genentech, NVIDIA Enter Into Strategic AI Research Collaboration (RTTNews)
20.11.23	Roche Unveils QPCR System To Advance Clinical Needs In Molecular Diagnostics (RTTNews)
20.11.23	Roche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges (PR Newswire)
16.11.23	Roche Launches Anti-HEV IgM, Anti-HEV IgG Immunoassays For Detection Of Hepatitis E Virus Infections (RTTNews)
14.11.23	Roche's Tecentriq Subcutaneous Injection Gets EU's CHMP Recommendation For Multiple Cancer Types (RTTNews)
09.11.23	Roche's Elecsys NfL Test For Multiple Sclerosis Receives Breakthrough Device Designation From FDA (RTTNews)
31.10.23	Roche: Elevidys Trial In DMD Fails To Meet Primary Endpoint, But Shows Positive Efficacy Outcomes (RTTNews)
27.10.23	Genentech's Vabysmo Gets FDA Approval To Treat Retinal Vein Occlusion (RTTNews)
26.10.23	Roche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses (PR Newswire)
23.10.23	Roivant Agrees With Roche To Acquire Telavant Holdings (RTTNews)
19.10.23	Roche 9M Group Sales Down On Weak COVID-19 Product Sales; Backs FY23 View (RTTNews)
18.10.23	Roche Receives First Approval For IL-6 Use With Newborns - Quick Facts (RTTNews)
18.10.23	Genentech: Alecensa Reduces Risk Of Disease Recurrence/ Death In ALK-Positive Early-Stage NSCLC (RTTNews)
17.10.23	Monte Rosa Therapeutics Inks Strategic Collaboration With Roche To Develop Molecular Glue Degraders (RTTNews)
13.10.23	Genentech Announces New Data From Phase II FENopta Study Of Fenebrutinib For People With RMS (RTTNews)
12.10.23	Roche: 10-year Efficacy Data Show MS Drug OCREVUS' Impact On Preventing Disability Progression (RTTNews)
11.10.23	Genentech's Ocrevus Effectively Manages MS Disease Activity In Black And Hispanic / Latinx People (RTTNews)
10.10.23	Genentech's Vabysmo Maintains Vision Improvements In Phase III Trials - Quick Facts (RTTNews)
04.10.23	Genentech: Majority Of Newborn Babies With SMA Treated With Evrysdi Able To Sit After 1 Yr Treatment (RTTNews)
20.09.23	PeptiDream Collaborates With Genentech For Discovery And Development Of Peptide-RI Drug Conjugates (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

25.06.24		Roche kann EU-Zulassung für Multiple-Sklerose-Mittel an Land ziehen - Aktie sinkt dennoch
10.06.24		Roche-Aktie dennoch tiefer: EU-Kommission lässt Lungenkrebsmedikament Alecensa zu
21.05.24		Roche-Aktie schwächer: Roche-Übernahme von LumiraDx in prüfung - Inavolisib erhält "Breakthrough Therapy"-Status
11.12.23		Roche-Aktie etwas fester: Roche legt Studiendaten zu Kadcyla, Hemlibra, Columvi und Lunsumio vor
02.02.23		Roche-Aktie schwächer: Roche erreicht 2022 Prognose - Umsatz- und Gewinnrückgang im neuen Jahr erwartet
27.12.22		Roche-Aktie leichter: FDA lässt Roches Lymphom-Behandlung Lunsumio zu
16.09.22		Roche-Aktie gewinnt: Moody's hebt Bonitätseinstufung für Roche an
25.04.22		Roche-Aktie leichter: Umsatz übertrifft Erwartungen